Clinical trials
Terminated Attention Deficit Disorder with Hyperactivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| Duke University | 3 |
| Eli Lilly and Company | 3 |
| Supernus Pharmaceuticals, Inc. | 3 |
| Florida International University | 2 |
| Milton S. Hershey Medical Center | 2 |
| Neurocentria, Inc. | 2 |
| New York State Psychiatric Institute | 2 |
| Purdue Pharma LP | 2 |
| Abbott | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 64 |
| Autism Spectrum Disorder | 4 |
| Spasm | 4 |
| Autistic Disorder | 2 |
| Brain Injuries, Traumatic | 2 |
| Marijuana Abuse | 2 |
| Attention Deficit and Disruptive Behavior Disorders | 1 |
| Bipolar Disorder | 1 |
| Cocaine-Related Disorders | 1 |
| Conduct Disorder | 1 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.